CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

BS PHARM KOREA Strengthens INHILO+ Market Development Through Distribution and Clinical Collaboration

PartnershipINHILO+Positive
AI Analysis

Summary

BS PHARM KOREA announced a distribution and clinical collaboration partnership with Dongkook Pharmaceutical for INHILO+, a dual-molecular hyaluronic acid skin booster, with an ongoing clinical evaluation program in South Korea.

Outcome Details

Distribution and clinical collaboration agreement with Dongkook Pharmaceutical; ongoing clinical evaluation program in South Korea

Importance:5/10
Sentiment:
0.40
partnershipdistributionclinical collaborationSouth Koreaskin care
Related Companies
$MOLN

Read the original article

Published by PR Newswire Pharma on September 6, 2026 12:00 PM

Read Original